Delivery Order SPE2DE21D7010-SPE2D625F4B0P

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $3.9K
Federal Agency
Medical Supply Chain
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
San Diego, CA 92121, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,427.00, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a fixed-price delivery order with economic price adjustment, with an ultimate completion date of April 30, 2025. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, has established itself as a key supplier of specialized spinal...
This federal contract award, valued at $8,427.00, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract is a Delivery Order under a Fixed Price with Economic Price Adjustment pricing type, with a period of performance through February 10, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract supports...
This federal contract award, valued at $34,971.70, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract is a Fixed Price with Economic Price Adjustment Delivery Order for the reline of open implants, with a completion date of January 6, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract supports the...
This federal contract award, valued at $8,427.00, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and the ultimate completion date is April 18, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract does not have a...
This federal contract award, valued at $17,360.46, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and has an ultimate completion date of February 21, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and operates as a for-profit...
This federal contract award, valued at $29,781.18, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type, and has an ultimate completion date of January 31, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract supports the...
This federal contract award, valued at $12,969.84, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed-price with economic price adjustment pricing type and an ultimate completion date of May 16, 2025. Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, is a key supplier of specialized medical...
This federal contract award, valued at $1,956.60, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The award is a Delivery Order under Contract SPE2DE21D7010|SPE2D625F33YB, with a fixed price and economic price adjustment pricing type. The contract has an ultimate completion date of February 7, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank...
This federal contract award, valued at $46,038.63, was issued by the Defense Logistics Agency (DLA) to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed price and economic price adjustment pricing type, with a period of performance ending on March 17, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, and the contract is part of a larger $8 million Blanket...
This federal contract award, valued at $7,230.26, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company that specializes in spinal surgery products and services. The contract is a Delivery Order with a Fixed Price with Economic Price Adjustment pricing type and an ultimate completion date of April 3, 2025. Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division and operates as a for-profit...
  • SPE2DE21D7010
    Indefinite Delivery Contract
  • SPE2DE21D7010-SPE2D625F4B0P
    Delivery Order

This federal contract award, valued at $3,897.50, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract is a delivery order with a fixed-price with economic price adjustment pricing type, and has an ultimate completion date of April 21, 2025.

Nuvasive, a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, is a key supplier of specialized medical technologies, implants, instruments, biologics, and related surgical equipment to federal healthcare agencies, primarily the Department of Defense (DoD), Department of Veterans Affairs (VA), and Defense Health Agency (DHA). The contract does not have a set-aside designation, indicating Nuvasive competes successfully in open market procurements. The award is part of Nuvasive's broader portfolio of federal contract vehicles, including an $8 million Blanket Purchase Agreement with the DHA that serves as an Indefinite Delivery/Indefinite Quantity contract through March 2027.

Generated 7/18/25, 9:59 AM